UVa Department of Neurology - What We Treat - Multiple Sclerosis - Clinical Trials

Search this Site
Keywords or Phrases View the Site Index

Health System Clinical Trials

Number of trials listed: 2 trials

Multiple Sclerosis

A 24-month Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Adm...

Contact:Margaret Keller Phone:(434)243-5457 E-mail:mfk8e@virginia.edu UVa Health System, Department of Neurology is looking for men and women ages 18 through 55 with relapsing-remitting Multiple Sclerosis (MS) with a documented rel...
Category: Neurology \| HIC : 12725
Department:Neurology \| Primary Investigator:Goldman Myla, D

Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy as measured by brain MRI l...

Contact:Margaret Keller Phone:(434)243-5457 E-mail:mfk8e@virginia.edu The purpose of the study is to investigate whether an experimental drug called ocrelizumab is safe and helpful in the treatment of relapsing-remitting MS. Eligi...
Category: Neurology \| HIC : 13827
Department:Neurology \| Primary Investigator:Simnad Virginia, I